ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Role of miRNA-671-5p in Mediating Wnt/β-Catenin-Triggered Podocyte Injury

Wang, Chunhong; Liu, Jiafeng; Zhang, Xiaoyao; Chen, Qiyan; Bai, Xiaoyan; Hong, Xue; Zhou, Lili*; Liu, Youhua*南方医科大学
Frontiers in Pharmacology2022-1-17DOI: 10.3389/fphar.2021.784489
7被引11閱讀
引用收藏
分享

摘要

Podocyte injury and proteinuria are the most common features of glomerular disease, which is the leading cause of end-stage renal failure. Hyperactivated Wnt/beta-catenin signaling is closely associated with podocyte injury, but the underlying mechanisms are incompletely understood. Here we show that miRNA-671-5p (miR-671-5p) plays a crucial role in mediating beta-catenin-triggered podocyte injury by targeting Wilms tumor 1 (WT1). Microarray-based expression profiling revealed that miR-671-5p was the most upregulated miRNA in podocytes after beta-catenin activation. MiR-671-5p was colocalized with beta-catenin in the glomeruli of proteinuric CKD in vivo. Bioinformatics analyses and luciferase reporter assays confirmed that miR-671-5p targeted WT1 mRNA. Overexpression of miR-671-5p mimics inhibited WT1 and impaired podocyte integrity, whereas miR-671-5p antagomir preserved the expression of WT1 and other podocyte-specific proteins under basal conditions or after beta-catenin activation. In mouse remnant kidney model, overexpression of miR-671-5p aggravated podocyte injury, worsened kidney dysfunction and exacerbated renal fibrosis after 5/6 nephrectomy. In contrast, miR-671-5p antagomir alleviated podocyte injury and attenuated proteinuria and renal fibrotic lesions after glomerular injury in vivo. These studies underscore a pivotal role of miR-671-5p in mediating WT1 depletion and podocyte injury induced by beta-catenin. Targeting miR-671-5p may serve as a new approach to prevent podocyte injury and proteinuria in proteinuric CKD.

學科與關鍵詞

關鍵詞
podocyte injuryWntbeta-cateninmiRNA-671-5pWT1proteinuria
相關
載入中…
  • Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis
    Zhou, Dong*; Wang, Yuanyuan; Gui, Yuan; Fu, Haiyan; Zhou, Shanshan; Wang, Yanlin; Bastacky, Sheldon I.; Stolz, Donna B.; Liu, Youhua*Kidney International, 2022, 102(1): 96-107.被引 4
  • Klotho-derived peptide 6 ameliorates diabetic kidney disease by targeting Wnt/β-catenin signaling
    Chen, Xiaowen; Tan, Huishi; Xu, Jie; Tian, Yuan; Yuan, Qian; Zuo, Yangyang; Chen, Qiyan; Hong, Xue; Fu, Haiyan; Hou, Fan Fan; Zhou, Lili*; Liu, Youhua*Kidney International, 2022, 102(3): 506-520.被引 19
  • B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathway
    Li, Jiemei; Niu, Jing; Min, Wenjian; Ai, Jun; Lin, Xu; Miao, Jinhua; Zhou, Shan; Liang, Ye; Chen, Shuangqin; Ren, Qian; Shen, Kunyu; Wu, Qinyu; Li, Xiaolong; Shen, Weiwei; Hou, Fan Fan; Liu, Youhua; Yang, Peng; Zhou, LiliCell Death and Differentiation, 2022, 29(12): 2399-2416.被引 7
查看全部 →

發表資訊

論文狀態
公開發表
期刊
Frontiers in Pharmacology
發表日期
2022-01-17
卷期
第 12 卷
頁碼
784489
DOI
10.3389/fphar.2021.784489
語言
ENGLISH
期刊等級
2区
成果收錄
SCIE
資助標註
National Natural Science Foundation of China [81521003, 81770715, 81920108007]

作者

  • W

    Wang, Chunhong (第一作者)

    southern med univ

  • L

    Liu, Jiafeng

    southern med univ

查看全部 8 位作者收起作者
  • Z

    Zhang, Xiaoyao

    southern med univ

  • C

    Chen, Qiyan

    southern med univ

  • B

    Bai, Xiaoyan

    southern med univ

  • H

    Hong, Xue

    southern med univ

  • Z

    Zhou, Lili (通訊)

    southern med univ

  • L

    Liu, Youhua (通訊)

    southern med univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417